- Home
- ORIQ vs SERA Comparison
ORIQ vs SERA Comparison
Compare ORIQ & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIQ
- SERA
- Stock Information
- Founded
- ORIQ 2024
- SERA 2008
- Country
- ORIQ Singapore
- SERA United States
- Employees
- ORIQ N/A
- SERA N/A
- Industry
- ORIQ
- SERA Precision Instruments
- Sector
- ORIQ
- SERA Health Care
- Exchange
- ORIQ Nasdaq
- SERA Nasdaq
- Market Cap
- ORIQ 87.6M
- SERA 90.6M
- IPO Year
- ORIQ 2025
- SERA 2021
- Fundamental
- Price
- ORIQ $10.18
- SERA $3.05
- Analyst Decision
- ORIQ
- SERA
- Analyst Count
- ORIQ 0
- SERA 0
- Target Price
- ORIQ N/A
- SERA N/A
- AVG Volume (30 Days)
- ORIQ 8.0K
- SERA 41.5K
- Earning Date
- ORIQ 01-01-0001
- SERA 11-13-2025
- Dividend Yield
- ORIQ N/A
- SERA N/A
- EPS Growth
- ORIQ N/A
- SERA N/A
- EPS
- ORIQ N/A
- SERA N/A
- Revenue
- ORIQ N/A
- SERA $95,000.00
- Revenue This Year
- ORIQ N/A
- SERA $217.92
- Revenue Next Year
- ORIQ N/A
- SERA $479.25
- P/E Ratio
- ORIQ N/A
- SERA N/A
- Revenue Growth
- ORIQ N/A
- SERA 1.06
- 52 Week Low
- ORIQ $9.98
- SERA $1.37
- 52 Week High
- ORIQ $10.20
- SERA $9.13
- Technical
- Relative Strength Index (RSI)
- ORIQ N/A
- SERA 49.51
- Support Level
- ORIQ N/A
- SERA $2.75
- Resistance Level
- ORIQ N/A
- SERA $3.18
- Average True Range (ATR)
- ORIQ 0.00
- SERA 0.28
- MACD
- ORIQ 0.00
- SERA -0.02
- Stochastic Oscillator
- ORIQ 0.00
- SERA 52.41
About ORIQ Origin Investment Corp I Ordinary Shares
Origin Investment Corp I is a blank check company.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.